Trials / Terminated
TerminatedNCT02211560
Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
A, Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Enzymotec · Industry
- Sex
- All
- Age
- 65 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the efficacy and safety of phosphatidylserine (PS) on cognitive abilities in MCI
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Phosphatidylserine | |
| OTHER | Placebo |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-12-25
- Completion
- 2017-12-25
- First posted
- 2014-08-07
- Last updated
- 2018-02-05
Locations
15 sites across 2 countries: United States, Israel
Source: ClinicalTrials.gov record NCT02211560. Inclusion in this directory is not an endorsement.